Using music to reduce apathy in Parkinson’s disease
Part of Brain & nervous system clinical trials.
This study tests whether music can help reduce apathy (low motivation) in people with Parkinson’s disease. It may help your mood and daily drive by targeting brain and behavior pathways tied to apathy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed Parkinson’s disease diagnosis based on standard criteria
- You should not have “atypical Parkinsonism,” like PSP or multiple system atrophy
- You must not have epilepsy
- You must not have other major brain or nerve conditions, like stroke, MS, or a significant brain lesion
- Your thinking (MoCA score) should be 21 or higher
- Your depression level should not be moderate or severe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether methylphenidate can reduce apathy (lack of motivation) in people with Parkinson’s disease. It may help if apathy has been persistent for weeks and your Parkinson’s medicines have been stable.
This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help improve apathy, or loss of motivation, in people with Parkinson's disease. You must have had symptoms for at least 4 years and be on stable Parkinson's medications.
This trial tests whether a gentle electrical stimulation on your ear (taVNS) can help improve low motivation (apathy) in people with Parkinson's. It also uses MRI scans to see how the treatment affects the brain.
This trial is testing whether a type of deep brain stimulation (called VC/VS-DBS) can help people with Parkinson's disease who have severe apathy (a loss of interest or motivation) that hasn't gotten better with medication. The goal is to see if this treatment can improve motivation and quality of life.
This study looks at “apathy,” or reduced motivation/interest, in people with schizophrenia or depression. It may help researchers understand what drives apathy and how to measure it in a clearer, more complete way.
This trial tests a new drug called IRL757 to see if it is safe and helps with apathy (loss of motivation or interest) in people with Parkinson's disease. You need to have at least moderate apathy and a caregiver who can come to visits with you.
Hear when a new Apathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.